These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15992173)

  • 1. Combating Gram-positive pathogens: emerging techniques to identify relevant virulence targets.
    Shea JE; Santangelo JD; Feldman RG
    Expert Opin Ther Targets; 2001 Apr; 5(2):155-64. PubMed ID: 15992173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-Wide Mutagenesis in Borrelia burgdorferi.
    Lin T; Gao L
    Methods Mol Biol; 2018; 1690():201-223. PubMed ID: 29032547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel pathogenicity genes by PCR signature-tagged mutagenesis and related technologies.
    Lehoux DE; Sanschagrin F; Kukavica-Ibrulj I; Potvin E; Levesque RC
    Methods Mol Biol; 2004; 266():289-304. PubMed ID: 15148424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in Detection Technologies of in vivo Expression of Bacterial Virulence Gene.].
    Chen SY; Mo ZL; Zhang ZD; Zou YX; Xu YL; Zhang PJ
    Yi Chuan; 2005 May; 27(3):505-11. PubMed ID: 15985422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signature-tagged mutagenesis in the identification of virulence genes in pathogens.
    Shea JE; Santangelo JD; Feldman RG
    Curr Opin Microbiol; 2000 Oct; 3(5):451-8. PubMed ID: 11050441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo expression technology and signature-tagged mutagenesis screens for identifying mechanisms of survival of zoonotic foodborne pathogens.
    Dudley EG
    Foodborne Pathog Dis; 2008 Aug; 5(4):473-85. PubMed ID: 18673072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A novel approach to study pathogenesis of pathogens in vivo--signature-tagged mutagenesis].
    Yao X; Huang LY; Yang BL; Su GF
    Yi Chuan; 2002 Nov; 24(6):721-6. PubMed ID: 15979978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing antibacterial vaccines in genomics and proteomics era.
    Kaushik DK; Sehgal D
    Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis.
    Jones AL; Knoll KM; Rubens CE
    Mol Microbiol; 2000 Sep; 37(6):1444-55. PubMed ID: 10998175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signature-tagged mutagenesis: technical advances in a negative selection method for virulence gene identification.
    Saenz HL; Dehio C
    Curr Opin Microbiol; 2005 Oct; 8(5):612-9. PubMed ID: 16126452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from signature-tagged mutagenesis on the infectious mechanisms of pathogenic bacteria.
    Autret N; Charbit A
    FEMS Microbiol Rev; 2005 Sep; 29(4):703-17. PubMed ID: 16102599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of genes essential in specific niches by signature-tagged mutagenesis.
    Lehoux DE; Levesque RC
    Curr Opin Biotechnol; 2000 Oct; 11(5):434-9. PubMed ID: 11024359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of virulence factors of pathogenic bacteria.
    Wu HJ; Wang AH; Jennings MP
    Curr Opin Chem Biol; 2008 Feb; 12(1):93-101. PubMed ID: 18284925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in functional genomics approaches to antifungal drug target discovery.
    De Backer MD; Van Dijck P
    Trends Microbiol; 2003 Oct; 11(10):470-8. PubMed ID: 14557030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IVET and RIVET: use of gene fusions to identify bacterial virulence factors specifically induced in host tissues.
    Slauch JM; Camilli A
    Methods Enzymol; 2000; 326():73-96. PubMed ID: 11036635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for isolation of in vivo expressed genes from bacteria.
    Handfield M; Levesque RC
    FEMS Microbiol Rev; 1999 Jan; 23(1):69-91. PubMed ID: 10077854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of virulence determinants for endocarditis in Streptococcus sanguinis by signature-tagged mutagenesis.
    Paik S; Senty L; Das S; Noe JC; Munro CL; Kitten T
    Infect Immun; 2005 Sep; 73(9):6064-74. PubMed ID: 16113327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signature-tagged mutagenesis.
    Kukavica-Ibrulj I; Levesque RC
    Methods Mol Biol; 2014; 1149():541-54. PubMed ID: 24818931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial pathogen genomes - new strategies for identifying therapeutic and vaccine targets.
    Opperman T; Ling LL; Moir DT
    Expert Opin Ther Targets; 2003 Aug; 7(4):469-73. PubMed ID: 12885266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.